Target intelligence / Profile preview

Ribosomal protein L23a pseudogene 90 (RPL23AP90)

Target
RPL23AP90
Molecular classification
Other (Pseudogene)
01

Overview

Ribosomal protein L23a pseudogene 90 (**RPL23AP90**) is an intronless, processed pseudogene located on human chromosome 1p21.2, with high sequence similarity to the coding gene for ribosomal protein L23a (RPL23A)[2][4][6][8]. Unlike the functional RPL23A gene, which codes for a component of the 60S large ribosomal subunit essential for protein synthesis, RPL23AP90 lacks the capacity to produce a functional protein and is classified as a pseudogene[1][2][4].\n There are many ribosomal protein L23a pseudogenes distributed throughout the human genome, often the result of retrotransposition events[3][9]. The specific function of RPL23AP90 has not been documented, and like most processed pseudogenes, there is no evidence that it serves as a therapeutic target, disease gene, or biomarker[1][2][4][6][8].\n Some ribosomal protein L23a pseudogenes (such as RPL23AP53) have been studied for changes in expression in specific cancer contexts, but RPL23AP90 itself has not been implicated in disease or therapeutic pathways[9].

Other names
RPL23AP90

Beyond the preview

Go deeper on Ribosomal protein L23a pseudogene 90 (RPL23AP90).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L23a pseudogene 90 (RPL23AP90).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call